Invion Limited
Invion Limited (IVIXF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ivixf · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Invion Limited (IVIXF) measures how much investors pay for each dollar of the company's trailing earnings. IVIXF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.12.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Invion LimitedYou IVIXF | $0M | N/A | — | -$0.12 |
 Acusphere, Inc. ACUS | $0M | N/A | — | -$12.60 |
 Aequus Pharmaceuticals Inc. AQSZF | $0M | N/A | — | -$0.02 |
 BioLife Sciences Inc. BLFE | $0M | N/A | — | -$0.02 |
 CBD Life Sciences Inc. CBDL | $0M | N/A | — | -$0.00 |
 Golden Developing Solutions, Inc. DVLP | $0M | N/A | — | -$0.00 |
 Hemp Naturals, Inc. HPMM | $0M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-0.08 | — | |
2024-06-30 FY2024 | — | $-0.09 | — | |
2023-06-30 FY2023 | — | $-0.02 | — | |
2022-06-30 FY2022 | — | $-0.03 | — | |
2021-06-30 FY2021 | — | $-0.02 | — | |
2020-06-30 FY2020 | — | $-0.01 | — | |
2019-06-30 FY2019 | — | $-0.01 | — | |
2018-06-30 FY2018 | — | $-0.09 | — | |
2017-06-30 FY2017 | — | $-0.11 | — | |
2016-06-30 FY2016 | — | $-0.24 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Invion Limited (IVIXF) measures how much investors pay for each dollar of the company's trailing earnings. IVIXF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.12.
Frequently asked questions
IVIXF pe ratio · 6 questionsIVIXF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.12. Data sourced from Financial Modeling Prep via IVIXF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Invion Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09